RAD51 and ovarian cancer: Study of Zhong et al. showed that depletion of cyclin D1 increased the sensitivity of ovarian cancer cells to olaparib through disturbing RAD51 accumulation and inducing cell cycle G0/G1 arrest [34, 35].